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Introduction
Cancer burden is increasing in sub-Saharan Africa, where 
one-third of  cancers are estimated to be caused by infectious 
agents.1,2 Head and neck squamous cell cancer (HNSCC) is 
the sixth most common malignancy in sub-Saharan Africa, 
including tumours in the oral cavity (OC), oropharynx 
(OP), nasopharynx, other pharynx, and larynx.1 Tobacco 
and alcohol exposure are established risk factors. However, 
human papillomavirus (HPV) is also a known cause 
particularly for OP cancer, especially in patients without 
tobacco or alcohol use. Incidence of  HPV-associated OP 
SCC is increasing in high-income countries, and HPV now 
accounts for more than 70% of  OP SCC compared to 20-
25% of  HNSCC at other sites.3–5
HPV is the causative agent of  cervical cancer, for which 
burden is extremely high throughout sub-Saharan Africa.1 
However, the contribution of  HPV to HNSCC in the 
region is largely unknown. Prior studies have used varying 
methodologies to detect HPV [immunohistochemistry 
(IHC), polymerase chain reaction (PCR), or a combination], 
often without detailed characterisation of  anatomic site or 
simultaneous evaluation of  other risk factors including HIV 
infection.6–9 We therefore sought to determine the presence 
of  HPV using p16 IHC among histologically confirmed 
HNSCC cases at Kamuzu Central Hospital (KCH), a national 
teaching hospital in Malawi’s capital, Lilongwe.
Methods
Histologically confirmed HNSCC cases diagnosed at KCH 
between September 2010 and April 2014 were studied. 
HNSCC was diagnosed using haematoxylin and eosin 
staining of  formalin-fixed paraffin-embedded (FFPE) 
tissue. All diagnoses were independently confirmed by 
senior pathologists in Malawi (NGL) and the US (WKF). 
Review by US pathologists was facilitated by the Aperio 
virtual microscopy system.10 Expression of  p16 was visually 
assessed by IHC using five micron FFPE sections and the 
Roche CINtec Histology Kit per manufacturer specifications 
(Roche Products Ltd, Randburg, South Africa).  All 
sectioning, staining, and IHC was performed manually in 
Malawi. Both study pathologists independently graded all 
specimens as negative (no p16 staining), intermediate (weak 
p16 staining in a minority of  cells), or positive (strong p16 
staining in a majority of  cells). Only specimens considered 
positive by both pathologists were considered positive in 
these analyses.
Demographic and clinical data, including HIV status, 
anatomic site, and substance use, were obtained from 
medical records. Data were compiled using a standardised 
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abstraction template. OP/OC sites were grouped together, 
since most patients presented with bulky tumours making 
it difficult to definitively assign tumour origin as OP or OC. 
In addition, some patients were identified via the pathology 
database alone without baseline assessment by dedicated 
study clinicians. Anatomic site was therefore often not well 
characterised for these patients.
Descriptive statistics were summarised and associations 
between variables determined using a Fisher’s exact test 
and t-test. All data were analysed using Stata 12 (StataCorp, 
College Station, Texas, USA). The study was approved by 
the Malawi National Health Science Research Committee 
and Institutional Review Board of  the University of  North 
Carolina.
Results
Histologically confirmed HNSCC cases diagnosed at KCH 
between September 2010 and April 2014 were studied. 
HNSCC was diagnosed using haematoxylin and eosin 
staining of  formalin-fixed paraffin-embedded (FFPE) 
tissue. All diagnoses were independently confirmed by 
senior pathologists in Malawi (NGL) and the US (WKF). 
Review by US pathologists was facilitated by the Aperio 
virtual microscopy system.10 Expression of  p16 was visually 
assessed by IHC using five micron FFPE sections and the 
Roche CINtec Histology Kit per manufacturer specifications 
(Roche Products Ltd, Randburg, South Africa). All sectioning, 
staining, and IHC was performed manually in Malawi. Both 
study pathologists independently graded all specimens as 
negative (no p16 staining), intermediate (weak p16 staining 
in a minority of  cells), or positive (strong p16 staining in 
a majority of  cells). Only specimens considered positive by 
both pathologists were considered positive in these analyses.
Demographic and clinical data, including HIV status, 
anatomic site, and substance use, were obtained from 
medical records. Data were compiled using a standardised 
abstraction template. OP/OC sites were grouped together, 
since most patients presented with bulky tumours making 
it difficult to definitively assign tumour origin as OP or OC. 
In addition, some patients were identified via the pathology 
database alone without baseline assessment by dedicated 
study clinicians. Anatomic site was therefore often not well 
characterised for these patients.
Descriptive statistics were summarised and associations 
between variables determined using a Fisher’s exact test 
and t-test. All data were analysed using Stata 12 (StataCorp, 
College Station, Texas, USA). The study was approved by 
the Malawi National Health Science Research Committee 
and Institutional Review Board of  the University of  North 
Carolina.
Discussion
Despite a concentration of  infection-associated cancers in 
sub-Saharan Africa including an immense burden of  HPV-
associated cervical cancer,11 and rising incidence of  HPV-
associated OP SCC in high-income countries,3–5 we found few 
HPV-associated HNSCC specimens at a national teaching 
hospital in Malawi as assessed by p16 IHC. Our study was 
limited by small sample size, as well as missing data, due 
to reliance on routine medical records for abstracting HIV 
status and clinical information. Nevertheless, these results 
may be valuable in light of  few studies specifically examining 
Table 1: Characteristics of 77 
confirmed head and neck 
squamous cell carcinoma cases in 
Lilongwe, Malawi
Characteristic
Male, n (%) 50 (65%)
Age, mean years (SD) 52.4 (16.8)
Tumour site, n (%)
Oropharynx/oral cavity 48 (62%)
Unknown primary 13 (17%)
Larynx 9 (12%)
Nasopharynx 6 (8%)
Hypopharynx 1 (1%)
HIV status, n (%)
Positive 5 (6%)
Negative 30 (39%)
Unknown 42 (55%)
Tobacco use, n (%)
Any 15 (20%)
None 25 (32%)
Unknown 37 (48%)
Alcohol use, n (%)
Any 12 (16%)
None 27 (35%)
Unknown 38 (49%)
SD = standard deviation
Table 1: Characteristics of 77 confirmed 
head and neck squamous cell carcinoma 
cases in Lilongwe, Malawi
Table 2: Characteristics by p16 immunohistochemistry status for 
42 head and neck squamous cell carcinoma cases in Lilongwe, 
Malawi
Characteristic
p16 
positive 
(n = 7)
p16 
negative 
(n = 35)
P-value
Male, n (%) 4 23 0.68
Age, mean years (SD) 49.1 (8.3) 54.3 (18.0) 0.47
Oropharynx/oral cavity, n (%) 5 (71%) 18 (51%) 0.43
HIV status, n (%)
Positive 1 (14%) 1 (3%) 0.43
Negative 3 (43%) 12 (34%)
Unknown 3 (43%) 22 (63%)
Tobacco use, n (%) –
Any 0 (0%) 3 (9%)
None 1 (14%) 3 (9%)
Unknown 6 (86%) 29 (83%)
Alcohol use, n (%) –
Any 0 (0%) 0 (0%)
None 1 (14%) 6 (17%)
Unknown 6 (86%) 29 (83%)
SD = standard deviation
l  : r t risti s   i ist c e istry status for 
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income countries with typically more advanced HIV illness 
prior to ART initiation. Therefore, Malawi may have still 
to realise epidemiologic transitions in its HIV-infected 
population that have occurred in other countries, where 
opportunistic infections and classical AIDS-defining cancers 
have been supplanted by non-AIDS-defining cancers and 
cardiovascular disease as principal causes of  morbidity and 
mortality, among aging HIV-infected populations effectively 
treated with ART.
In summary, HPV-associated HNSCC as assessed by p16 
IHC was uncommon in our small series at a national teaching 
hospital in Malawi. Continued HNSCC surveillance in Malawi 
will be important to fully understand the importance of  
this disease moving forward, ideally through larger regional 
collaborations across sub-Saharan Africa which can provide 
more definitive results. This will be particularly important 
as ART coverage increases for HIV-infected individuals, 
behavioural practices change, and HPV vaccination becomes 
available. Finally, if  established risk factors including tobacco, 
alcohol, and HPV do not collectively account for most 
HNSCC in sub-Saharan Africa, high-quality epidemiologic 
studies are urgently needed to identify aetiologic agents in 
HNSCC development which may be unique to the region. 
These vital data can inform prevention efforts in settings 
where treating established HNSCC is difficult due to resource 
limitations, including exceedingly scarce radiotherapy.
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